Year archive

CANbridge Pharmaceuticals Inc. — 2023 filings

All 32 regulatory filings released by CANbridge Pharmaceuticals Inc. (1228) in 2023, sourced directly from the official regulator.

32 Filings

2023 Period

2023 filings (32)

Filing	Released	Lang
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2023 Regulatory Filings	2023-12-05	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2023-11-23	English
RESIGNATION OF NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF BOARD COMMITTEE Board/Management Information	2023-11-23	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2023 Regulatory Filings	2023-11-06	English
NEXT DAY DISCLOSURE RETURN Share Issue/Capital Change	2023-10-24	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2023 Regulatory Filings	2023-10-06	English
INTERIM REPORT 2023 Interim / Quarterly Report	2023-09-27	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2023 Regulatory Filings	2023-09-06	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023 Interim / Quarterly Report	2023-08-31	English
NOTICE OF DATE OF BOARD MEETING Regulatory Filings	2023-08-18	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2023 Regulatory Filings	2023-08-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Capital/Financing Update	2023-07-05	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 27, 2023 Declaration of Voting Results & Voting Rights Announcements	2023-06-27	English
VOLUNTARY ANNOUNCEMENT ANNOUNCEMENT OF PRELIMINARY CLINICAL DATA OF PHASE 1B STUDY OF OMOPRUBART (CAN106) IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) Regulatory Filings	2023-06-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023 Share Issue/Capital Change	2023-06-06	English
INSIDE INFORMATION ANNOUNCEMENT LIVMARLI (MARALIXIBAT ORAL SOLUTION, CAN108) OBTAINED MARKETING APPROVAL IN CHINA Regulatory Filings	2023-06-02	English
CHANGE OF PROCESS AGENT Regulatory Filings	2023-05-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023 Regulatory Filings	2023-05-05	English
2022 Environmental, Social and Governance Report Environmental & Social Information	2023-04-26	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, JUNE 27, 2023 AGM Information	2023-04-26	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2023-04-26	English
(1) PROPOSED GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; AND (4) NOTICE OF ANNUAL GENERAL MEET AGM Information	2023-04-26	English
2022 ANNUAL REPORT Annual Report	2023-04-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023 Regulatory Filings	2023-04-11	English
Terms of Reference for the Remuneration Committee Remuneration Information	2023-03-31	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022 Annual Report	2023-03-31	English
NOTICE OF DATE OF BOARD MEETING Regulatory Filings	2023-03-20	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2023-03-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 Regulatory Filings	2023-03-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 Share Issue/Capital Change	2023-02-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 Share Issue/Capital Change	2023-01-05	English
VOLUNTARY ANNOUNCEMENT UPDATE ON COLLABORATIONS WITH THE UMASS CHAN MEDICAL SCHOOL AND WITH LOGICBIO THERAPEUTICS Regulatory Filings	2023-01-04	English